semaglutide patent novo nordisk Settles Ozempic Case Novo Nordisk scores court win

BPC-157 Side Effects: What the Research Literature Reports What the published in-vitro and animal-model literature reports about BPC-157 tolerability for laboratory documentation

Nat Metab 2024;6:290303

Metabolic Adaptation Weight loss triggers metabolic adaptations as the body adjusts to a lower energy state

I do not think everyone needs to be on a GLP-1 despite what the advertising world has to say

This disposal requirement exists because the preservative system in the multi-dose pen may no longer guarantee sterility beyond this period

Per the Centers for Disease Control and Prevention (CDC), using NHANES 2017March 2020 data, 41.9% of US adults have obesity (BMI 30) the population for whom GLP-1 telehealth was built